# Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination

> **NCT01627938** · PHASE2 · UNKNOWN · sponsor: **PD Dr. Andrew Chan** · enrollment: 50 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Dexrazoxane (DRZ) plus Mitoxantrone (MX)
- **DRUG:** Placebo plus Mitoxantrone (MX)

## Key facts

- **NCT ID:** NCT01627938
- **Lead sponsor:** PD Dr. Andrew Chan
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-04
- **Primary completion:** 2015-04
- **Final completion:** 2016-04
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2014-11-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01627938

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01627938, "Study to Evaluate the Reduction of Cardiac Problems in Multiple Sclerosis Patients With Mitoxantrone and Dexrazoxane in Combination". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01627938. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*